MYCN and neoplasm: The PROTAC compound JQAD1 selectively targets p300 protein for degradation, reduces the transcription of critical oncogenes such as MYCN, and induces neuroblastoma cell apoptosis in vitro and tumor growth inhibition in mouse models 100.